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76 The Journal of Thoracic and Cardiobjective: To determine the safety and efficacy of endoscopic mitral valve surgery
sing robotic instruments through the lateral right chest.
ethods: We conducted a retrospective review of 127 patients taken to the oper-
ting room for endoscopic robotic mitral surgery from December 2002 through
ovember 2005. Mean age was 54  13 years and 58% were male. Mitral
egurgitation was 4 in 121 patients, 3 in 4 patients, and 2 in 2 patients.
ineteen (15%) patients had a left ventricular ejection fraction of 0.50 or less.
urgical approach was through 4 right chest ports with femoral perfusion and
ndoaortic balloon occlusion. Mean follow-up was 13.7  8.9 months and was
00% complete. Echocardiographic follow-up was available on 98 patients with a
ean of 8.4  8.1 months.
esults: The mitral procedure was completed endoscopically in 121 (95%) patients.
itral valve repair was performed in 114 patients and mitral valve replacement in
patients. Two patients required reoperation on the mitral valve. There was 1
0.8%) hospital death and 1 late death. Echocardiographic follow-up in 98 survivors
f endoscopic mitral repair revealed 0-1 regurgitation in 95 (96.9%) and 2 in 3
3.1%) patients.
onclusions: Totally endoscopic mitral surgery can be performed safely with
obotic instrumentation. A right lateral configuration of the robotic system allows
xcellent visualization of the valve with minimal distortion and permits two surgical
ersonnel to participate actively in valve instrumentation. In selected patients with
itral valve disease, this surgical approach might promote higher rates of valve
epair.
he value of a mitral valve operation is directly related to the efficacy of the
procedure performed on the valve and inversely related to the invasiveness
necessary to achieve it. This value can be maximized if a high rate of
uccessful valve repairs can be achieved with a least invasive approach. Although
he principles of mitral valve repair were described more than 20 years ag1 the
epair rate for isolated mitral valve disease in the United States remains below
0%.2,3 Mitral valve repair requires the surgeon to understand mitral valve p
hysiology and to have a surgical strategy to correct it.4 Even armed with th
nowledge, however, the surgeon must have the ability to expose the valve and
uccessfully instrument it. The advantages of mitral valve repair over replacement
nvolve potentially lifelong benefits to the patient, including preservation of ven-
ricular function and avoidance of anticoagulation.5 Any change in surgical ap-
vascular Surgery ● October 2006
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A
CDroach to mitral valve surgery primarily has to afford the
urgeon the opportunity to expose and instrument the mitral
alve structures and achieve a maximum valve repair rate.
he advantages of performing the mitral procedure through
less invasive approach include the potential benefits of
ewer wound complications, less blood loss, faster recovery,
nd a more acceptable cosmetic result, but these advantages
re of a more transitory nature and must have a lower
riority than achieving valve repair. Possibly because of
imitations in exposure and instrumentation and prolonged
perative times, minimally invasive approaches to mitral
alve repair have not been widely applied.6,7 In an effort t
aximize the value of mitral valve procedures, we reviewed
he landmark work of Starr and Edwards8 published in 1963
n mitral valve surgery using a lateral right chest approach
o the left atrium. Illustrations of their direct approach to the
itral valve through the left atrium demonstrate excellent
xposure and minimal distortion of the valve structures
hile employing limited retraction of the atrial septum.
tarr used a large right thoracotomy and conventional in-
truments to perform mitral procedures through this ap-
roach. Over 40 years later with development of peripheral
atheter-based cardiopulmonary bypass9 and robotic instru-
entation technology,10 we report on our initial effort
uplicate the exposure and instrumentation experienced by
tarr while providing the patient the benefits of a totally
ndoscopic procedure.11,12
ethods
rom December 2002 through November 2005, a total of 127
atients were taken to the operating room for endoscopic robotic
itral surgery. These patients represent 57% of our patients un-
ergoing isolated mitral surgery during the 3-year period. Patients
ith a heavily calcified mitral annulus, right pleural scarring, or
evere aortoiliac atherosclerosis were routinely approached by
edian sternotomy. Patients with previous median sternotomy or
eed for concomitant tricuspid repair were approached by minitho-
acotomy. All patients were fully informed of their surgical ap-
roach options.
atient Characteristics
he mean age of the patients was 54  13 years (21-78 years) and
8% were male. New York Heart Association functional class was
in 11 (8.7%) patients, II in 55 (43.3%) patients, III in 45 (35.4%)
atients, and IV in 16 (12.6%) patients. A history of hypertension
as present in 62 (48.8%) patients and a history of continuous or
ntermittent atrial fibrillation was present in 17 (13%) patients.
ean body mass index was 27.2  17.2 (17-30.5). Twenty pa-
ients (16%) had a body mass index over 30 and 3 patients had an
ndex over 35. Two patients had pectus excavatum. Preoperative
itral regurgitation assessed by echocardiography was 4 in 121
atients, 3 in 4 patients, and 2 in 2 patients (1 with an atrial
eptal defect and 1 with an accessory mitral leaflet obstructing left
entricular outflow13). Mean left atrial size was 44.9  7.6 mm.
ean left ventricular end-diastolic diameter was 52.7  8.8 mm. c
The Journal of Thoracicreoperative mean left ventricular ejection fraction was 57.9% 
.2% (25%-75%). Nineteen (15%) patients had a preoperative left
entricular ejection fraction of 50% or less. All patients underwent
unctional valve assessment by transesophageal echocardiography
nd classification according to Carpentier with valve disease con-
rmed at surgery (Table 1). All procedures were elective exce
patients who required urgent surgery for refractory congestive
eart surgery.
urgical Technique
he patient is intubated with a double-lumen endotracheal tube
nd transesophageal echocardiography is used by the anesthesiol-
gist to position coronary sinus cardioplegia and pulmonary artery
ent catheters. After the patient has been positioned in the supine
osition with the right side of the chest elevated, the femoral
essels are exposed. The right lung is then deflated and the
ndoscope of the da Vinci Robotic Surgical System (Intuitive
urgical, Sunnyvale, Calif) is inserted through a 12-mm port
laced in the fourth or fifth intercostal space at or just medial to the
ight anterior axillary line. The 30° up endoscope with the “wide
ngle” da Vinci camera is moved manually to confirm access to the
ediastinum. The handle of the atrial septal retractor is then
nserted through a 16F introducer set (Cook, Bloomington, Ind) in
he same intercostal space as the endoscope just lateral to the right
nternal thoracic artery. The endoscope is removed and a 37-mm
ervice port incision is made in the same intercostal space 20 to 30
m lateral to the endoscope port. With the surgeon’s finger in this
ervice port to protect intrathoracic structures, trocars for the
obotic instrument arms, 14-gauge angiocatheters for traction su-
ures and infusion of carbon dioxide, and a 20F DLP cardiac sump
Medtronic, Inc, Minneapolis, Minn) for left atrial suction are
nserted. Right chest preparation is depicted in Figure 1.
The patient is then heparinized and the femoral vessels are
ABLE 1. Echocardiographic and operative mitral valve
haracteristics (n  127)
ariable n %
arpentier classification
Type 1 12 9.4
Type 2 108 85.0
Anterior prolapse 15 11.8
Posterior prolapse 67 52.7
Bileaflet prolapse 26 20.4
Type 3 7 5.6
alve pathology
Degenerative 107 84.3
Fibroelastic deficiency 72 56.7
Barlow 35 27.6
Isolated annular
dilatation
12 9.4
Rheumatic 5 3.9
Congenital 1 0.8
Radiation induced 1 0.8
Hypertrophic
cardiomyopathy
1 0.8annulated for Port Access11 (Cardiovations, Somerville, NJ).
and Cardiovascular Surgery ● Volume 132, Number 4 777
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A
CDhe da Vinci instrument cart is rolled to the patient’s left side
nd the instrument arms and endoscope are placed in their
espective ports. A 20-mm. flexible port (Ethicon Endo-Sur-
ery, Cincinnati, Ohio) is temporarily placed in the service port
ncision. The surgeon moves to the da Vinci console. The first
ssistant moves to the patient’s right side. Manual occlusion of
he service port allows carbon dioxide insufflation to create
orking space in the right side of the thorax. Pericardiotomy is
erformed robotically and traction sutures on the pericardium
nd diaphragm are drawn out laterally through the angiocath-
ters. The endoscope is then changed to the “high mag” da
inci camera. Cardiopulmonary bypass is initiated, endoaortic
alloon occlusion is achieved, and cardioplegic solution is
dministered. A hardshell port (ATS Medical, Minneapolis,
inn) is then positioned in the service port. The left atrium is
pened at the junction of the pulmonary veins. A 35-mm wide
trial septal retractor blade is passed through the service port
nto the left atriotomy and connected to the previously placed
andle. The atrial septum is retracted to visualize the mitral
alve with the 30° up endoscope. Surgical tasks on the mitral
tructures are then performed with the two robotic instrument
rms assisted by the patient-side assistant using shafted instru-
ents through the service port. Running suture lines are facil-
tated by use of a suture retrieval hook (ATS Medical), allowing
he suture needle to be retained in the robotic needle driver. All
not tying is performed extracorporeally by the assistant using
shafted knot pusher. Mitral repair techniques are the same as
hose that we use on conventional mitral approaches except for
he use of V-100 nitinol clips (Medtronic, Minneapolis, Minn)
or flexible annuloplasty band or ring attachment.14 All mitral
alve replacements are performed with pledget-supported su-
ures placed robotically and then passed through the sewing ring
nd tied extracorporeally by the assistant. Valve sizers (ATS
edical) designed to be compatible with robotic instruments
igure 1. Right chest port preparation. E, endoscopic; L, left
obotic arm; S, service port; R, right robotic arm; V, left atrial
uction catheter.re used. Concomitant left atrial ablation, when indicated, is (
78 The Journal of Thoracic and Cardiovascular Surgery ● Octoerformed by cryoablation catheter (Cryocath, Montreal, Que-
ec, Canada) through the service port. Left atrial appendage
losure is performed with running polytetrafluoroethylene su-
ure (Gore-Tex suture; W. L Gore & Associates, Inc, Flagstaff,
riz). Deairing is achieved by placing the flexible left atrial
uction catheter across the repaired mitral valve at the time of
eft atrial closure. With valve replacement, the left atrial suction
atheter remains in the left atrium and the mechanical valve is
aintained incompetent with a small Foley catheter.
ollow-up
urability of the repair was measured by echocardiographic valve
unction and the incidence of valve reoperation. Patient follow-up
as performed in December 2005 to obtain clinical and echocar-
iographic status with data expressed as means  standard devi-
tion. The mean follow-up was 13.7 8.9 months (0.5-36 months)
nd was 100% complete.
esults
echnical Feasibility
onversion to a median sternotomy incision was necessary
n 5 patients and to a small thoracotomy with rib spreading
n 1 patient (Table 2). All patients recovered uneventf
he mitral procedure was completed endoscopically in 121
atients (95%). Mitral valve replacement was necessary in 7
5.8%) of the 121 patients. The valve pathology was Barlow
isease in 3 of these 7 patients, endocarditis in 2 patients (1
nfectious and 1 Libman-Sacks endocarditis), radiation-
nduced valve damage in 1 patient, and hypertrophic ob-
tructive cardiomyopathy in 1 patient. All patients received
echanical valves. Mean aortic occlusion time was 146 
0 minutes (126-183 minutes) and mean cardiopulmonary
ypass time was 182  27 minutes (154-236 minutes).
ntraoperative transesophageal echocardiography revealed
ppropriate prosthesis function in all patients undergoing
alve replacement. Mitral valve repair was completed in
14 patients. The techniques used for mitral valve repair as
ell as concomitant procedures are presented in Tabl
ean aortic occlusion time was 102  28 minutes (47-182
inutes) and mean cardiopulmonary bypass time was 131
34 minutes (72-234 minutes). Inotropic support was
ecessary to wean from cardiopulmonary bypass in 18
ABLE 2. Conversions from endoscopic robotic approach
atient No. Reason for conversion Procedure
1 Ruptured breast implant Repair through MS
6 Insufficient venous return Repair through MS
9 Vision system failure Replacement through MS
19 Femoral arterial disease Repair through MS
22 Insufficient working space Repair through MT
87 Marked aortic tortuosity Repair through MS
S, Median sternotomy; MT, minithoracotomy.15%) patients treated by endoscopy, and no patient re-
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A
CDuired an intra-aortic balloon pump. One patient with pre-
perative complete heart block required temporary pacing.
itral regurgitation was grade 0 in 104 (91.3%) patients,
rade 1 in 9 (7.9%) patients, and grade 2 in 1 (1.8%)
atient among those undergoing mitral repair.
erioperative Course
here was 1 hospital death (0.8 %). A 75-year-old man
equired mitral valve replacement through a median ster-
otomy for severe systolic anterior motion 1 day after mitral
alve repair. His subsequent course was complicated by
troke and multisystem failure with death on postoperative
ay 48. Postoperative complications are detailed in Tabl
ransfusion of blood products was required in 37 (31%)
atients. Three (2.5%) patients were returned to surgery for
leeding. In 2 patients the exploratory procedure was done
hrough the existing ports for bleeding from intercostal
ites, but 1 required a median sternotomy for bleeding from
he left atrial suture line. The total number of all patients
ho required a median sternotomy incision during the
-year experience was 7 (5.5%). One patient who presented
n complete heart block received a permanent pacemaker.
wo patients required mechanical ventilation for more than
4 hours, and except for the patient who died, no patient had
espiratory failure. Intensive care unit stay was less than 24
ours in 94% of mitral repair patients and 57% of mitral
eplacement patients. The mean stay from surgery to dis-
harge in mitral repair patients was 4.5  2.7 days (2-48
ays), with 62 % of patients discharged in 4 days or less.
he mean stay after surgery for mitral valve replacement
as 9.1  7.5 days (4-25 days). No patient was discharged
o extended care.
ostoperative Outcome
ive patients (0.4%) were readmitted within 30 days of
ischarge: 3 for atrial fibrillation, 1 for groin wound cellu-
ABLE 3. Valve repair techniques and concomitant proce-
ures (n  114)
epair or procedure n %
osterior leaflet resection 77 67.5
nterior leaflet resection 15 13.2
olytetrafluoroethylene neochordae 26 22.8
nterior leaflet plication 2 1.7
ommissurotomy 2 1.7
eaflet pericardial patch 2 1.7
nnuloplasty ring 6 5.3
nnuloplasty band 107 93.9
trial ablation 8 7.0
eft atrial appendage closure 8 7.0
ericardial patch of atrial septal defect 1 0.8
uture closure of patent foramen ovale 8 7.0itis, and 1 for gastrointestinal hemorrhage. One patient had m
The Journal of Thoracicparavalvular leak 6 weeks after mitral valve replacement
nd underwent successful repair through a minithora-
otomy. There was 1 late death of a patient with dilated
ardiomyopathy treated with ring annuloplasty who died
uddenly 2 months after mitral repair surgery. Follow-up
chocardiogram 1 month postoperatively had revealed only
ild regurgitation, and at autopsy the valve repair was
ntact. Of the 121 patients whose operations were completed
ndoscopically 107 (88.4%) had returned to full activity
evel by 3 weeks after the operation. The New York Heart
ssociation functional class in 119 surviving endoscopic
atients was class I in 109 (91.6%) patients, class II in 8
6.7%) patients, and class III in 2 (1.7%) patients. Postdis-
harge echocardiographic results were available in 98 mitral
alve repair patients with a mean follow-up of 8.4  8.1
onths (1.5-33.4 months). Eighty-seven (88.8%) patients
ad 0 regurgitation, 8 (8.2%) patients had 1 regurgitation,
nd 3 (3.1%) patients had 2 regurgitation.
iscussion
ith a right thoracotomy involving the entire fifth intercos-
al space, Starr was among the first surgeons to gain excel-
ent exposure of the mitral valve and successfully replace it
ith the use of conventional instruments. The right lateral
horacotomy was subsequently abandoned in favor of the
edian sternotomy, which allows direct access to the as-
ending aorta and all cardiac structures. For mitral valve
xposure, however, either substantially more atrial septal
etraction or more extensive cardiotomy is required than
ith the right thoracotomy approach.15 For the past decad
n patients at low risk for retrograde femoral artery perfu-
ion, surgeons have labored to return to the lateral approach
sing a small right anterolateral thoracotomy with or with-
ut rib spreading, shafted surgical instruments, and 2-di-
ABLE 4. Postoperative complications (n  121)
ype of complication n %
ew-onset atrial fibrillation 22 18.2
yocardial infarction 0 0
ow cardiac output 0 0
neumonitis 2 1.6
entilation  24 h 2 1.6
rolonged air leak 1 0.8
ight pleural effusion 2 1.6
hest incision infection 0 0
ransient renal dysfunction 1 0.8
troke 2 1.6
imb ischemia 0 0
eep venous thrombosis 0 0
ortic dissection 0 0
roin wound cellulitis 1 0.8
roin lymphocele 2 1.6ensional endoscopy.11,15-18 Widespread adoption of this
and Cardiovascular Surgery ● Volume 132, Number 4 779
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7
A
CDpproach has been impeded by concerns regarding limita-
ions of 2-dimensional vision, challenging instrumentation,
nd incomplete deairing.15,17 Using this same anterolatera
pproach, Nifong and associates10 demonstrated that roboti
nstrumentation could be used for complex mitral repair
ith the advantages of 3-dimensional vision and enhanced
nstrumentation. By marrying the technologies of endoaor-
ic balloon occlusion with robotic instrumentation, we have
volved back to the more lateral thoracic approach to the
itral valve described by Starr without the morbidity of a
arge thoracotomy. The endoaortic balloon technology is an
mportant ingredient in moving this approach laterally be-
ause this catheter has antegrade cardioplegia and venting
apability and hence requires no direct instrumentation of
he ascending aorta. Approaching the mediastinum from the
ore lateral chest allows more working space for pericar-
iotomy and placement of traction sutures before initiating
ardiopulmonary bypass. Since the approach is endoscopic,
his working space can be enhanced by pressurizing the
ight pleural space by insufflation of carbon dioxide. This
echnique also has the advantage of creating high carbon
ioxide levels in the left cardiac chambers, potentially re-
ucing the risk of air embolism.19
The lateral endoscopic robotic mitral approach has af-
orded this series of patients cardiac surgery with minimal
hest wall trauma. More important, it has afforded a high
itral valve repair rate, which we attribute to enhanced
isualization of the valve, robotic instrumentation, and ac-
ive participation of the patient-side assistant.
Although excellent visualization of the mitral valve can
ften be achieved with 2-dimensional endoscopy, the ab-
ence of depth perception can be a significant handicap in
omplex mitral repair.15 Even minor adjustments of t
ndoscope to improve the visual field require the surgeon to
nterrupt surgical activities with handheld instruments. Al-
ernatively, the surgeon can achieve 3-dimensional vision
hrough the chest incision, but this usually requires rib
preading and positioning of the surgeon’s head to the focal
ength of magnifying loupes. With the da Vinci Robotic
ystem, the dual-camera endoscope provides 3-dimensional
ision to the surgeon and 2-dimensional vision to the assis-
ants. The console surgeon can adjust the visual field of the
ndoscope without releasing the instrument controls. Ni-
ong,10 Reade,14 and their colleagues described the robo
ndoscope inserted through an anterolateral thoracotomy.
ith the endoscope inserted more laterally near the anterior
xillary line, the amount of atrial septal retraction necessary
o visualize the mitral structures is reduced. Less atrial
eptal retraction is valuable in reducing valve distortion.
Instrumentation of the mitral structures with handheld
hafted instruments can be very challenging. A more lateral
pproach, large thoracic size, obesity, and pectus excavatum
ll increase the distance from the skin to the mitral struc- t
80 The Journal of Thoracic and Cardiovascular Surgery ● Octoures and increase this challenge. Also, unlike the large
horacotomy approach described by Starr, in which the
urgeon’s wrists could be placed inside the thorax, the
inimally invasive surgeon’s wrists remain extracorporeal,
ermitting only limited manipulations of the valve struc-
ures with shafted instruments. With the surgeon holding
wo shafted instruments nearly parallel through the small
horacotomy or working port, instrument interactions can be
ifficult or even conflicting. The da Vinci robotic instru-
ents extend 24 cm from the pivot point in the chest wall to
he instrument wrist, providing a stable instrument platform
t or below the mitral annulus in almost all clinical situa-
ions. Although the robotic instrument wrists are not as
obile as human wrists, they are positioned intracorpore-
lly near the instrument tip and provide adequate degrees of
reedom for tissue and suture manipulation.10 In addition,
nlike shafted instruments, which are routinely used though
single intercostal space, the robotic instruments are in-
erted 2 to 3 intercostal spaces apart and are triangulated
ith the endoscope, mimicking conventional surgical ori-
ntation and minimizing conflicts.
Although the vision and instrument advantages of the da
inci Robotic System are important in the mitral repair
apability of this lateral endoscopic approach, the greatest
dvantage is the ability of the patient-side assistant to par-
icipate actively in the instrumentation of the valve. Two
actors create this enhanced assistant role. First, the robotic
nstruments are delivered into the operative field from the
nstrument cart, which is positioned at the patient’s left side.
his orientation allows the assistant to stand on the patient’s
ight side with access to the operative field through the
ervice port. Second, in contrast to the anterolateral ap-
roach, when the service port is positioned lateral to the
ndoscope and between the robotic arms, the assistant’s
nstruments can reach the mitral structures directly with
inimal interference from the atrial retractor blade, endo-
cope, or robotic instruments. By having up to 4 instruments
t the operative site (2 handheld, 2 robotic), surgical tasks
an be greatly facilitated. Cutting and suturing can be per-
ormed by the console surgeon, who has 3-dimensional
ision and intracorporeal robotic wrists, while suctioning of
lood, retraction, and suture retrieval can be simultaneously
erformed by the patient-side assistant. All knot tying can
e performed by the patient-side assistant under the endo-
copic surveillance of the console surgeon. In our experi-
nce, extracorporeal tying can be performed faster and more
ccurately than robotic tying. This teamwork is particularly
elpful in the construction of new polytetrafluoroethylene
hordae where the proper length of the new chord is main-
ained with the robotic instruments while the assistant per-
orms the knot tying. This synergism between the console
urgeon and the patient-side assistant was a major factor in
he high valve repair rate achieved in this series of patients.
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A
CDThe duration of follow-up in this report is short, and
ong-term durability of these mitral procedures remains to
e validated, although the outcome may be more a reflection
f the repair techniques used than of the instrumentation and
pproach employed. This technique uses retrograde femoral
rtery perfusion and should not be applied in patients with
dvanced atherosclerosis or marked tortuosity of the aorta.
ardiopulmonary bypass duration was relatively long with
his approach, although morbidity was comparable with or
etter than the national data.2 Aortic occlusion time wa
lso long with this technique, especially if valve replace-
ent was necessary, but was well tolerated as evidenced by
xcellent postoperative function. It should be noted that
etrograde cardioplegia was used in nearly every patient. A
ossible major limitation of this technique is the increased
perative costs of robotic instrumentation and catheter dis-
osables. Much of this increased cost, however, might be
ffset by the lower costs of valve repair and subsequent
ospitalization. This approach does require the assembly
nd training of a consistent team of anesthesia, surgical,
ursing, and perfusion personnel and might not be applica-
le to all cardiac surgical programs.
onclusions
obotic instrumentation provides a safe and effective vision
nd instrument platform at the mitral valve when used
hrough a lateral right chest endoscopic approach. This
onfiguration of the robotic system allows 2 surgical per-
onnel to participate actively in instrumentation of the mi-
ral valve structures and might promote higher rates of valve
epair in selected patients.
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